US FDA approves Pfizer, Arvinas' breast cancer drug
- Posted on May 1, 2026
- By Bing News
- 0 Views
- 1 min read
US FDA approves Pfizer, Arvinas' breast cancer drug
By Padmanabhan Ananthan May 1 (Reuters) - The U.S. Food and Drug Administration on Friday approved Pfizer and Arvinas' breast cancer drug for patients with an advanced form of the disease whose tumors carry a specific genetic mutation. Branded as Veppanu, the pill is authorized for adults with estrogen receptor-positive, HER2-negative breast cancer, which has already spread or cannot be removed
